{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:26:05Z","timestamp":1793190365708,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"ASISA Foundation"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS086659"],"award-info":[{"award-number":["U01NS086659"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH100350"],"award-info":[{"award-number":["R01MH100350"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Economy and Competitiveness - State Secretariat for Research, Development and Innovation of Spain","award":["SAF 2015-66603-P"],"award-info":[{"award-number":["SAF 2015-66603-P"]}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG005134"],"award-info":[{"award-number":["AG005134"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG036694"],"award-info":[{"award-number":["AG036694"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer's Disease Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00401-017-1740-8","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T11:29:04Z","timestamp":1497353344000},"page":"619-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging"],"prefix":"10.1007","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-0950","authenticated-orcid":false,"given":"Marta","family":"Marqui\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Siao Tick Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ant\u00f3n-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline E.","family":"Verwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"S\u00e1ez-Calveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery C.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prianca","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"G\u00f3mez-Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. doi:\n                    10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"1740_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1740_CR3","doi-asserted-by":"publisher","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab Jet al (2016) Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 8:338ra366. doi:\n                    10.1126\/scitranslmed.aaf2362","DOI":"10.1126\/scitranslmed.aaf2362"},{"key":"1740_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5\u201322. doi:\n                    10.1007\/s00401-007-0237-2","journal-title":"Acta Neuropathol"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimer\u2019s Dis JAD 34:457\u2013468. doi:\n                    10.3233\/JAD-122059","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH (2016) In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol 80:247\u2013258. doi:\n                    10.1002\/ana.24711","journal-title":"Ann Neurol"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","volume":"87","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, Lyoo CH, Ryu YH, Lee MS (2016) Tau PET in Alzheimer disease and mild cognitive impairment. Neurology 87:375\u2013383. doi:\n                    10.1212\/WNL.0000000000002892","journal-title":"Neurology"},{"key":"1740_CR8","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/aww139","volume":"139","author":"BA Gordon","year":"2016","unstructured":"Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ et al (2016) The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain J Neurol 139:2249\u20132260. doi:\n                    10.1093\/brain\/aww139","journal-title":"Brain J Neurol"},{"key":"1740_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 8:1\u201313. doi:\n                    10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K et al (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79:110\u2013119. doi:\n                    10.1002\/ana.24546","journal-title":"Ann Neurol"},{"key":"1740_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","volume":"132","author":"KA Josephs","year":"2016","unstructured":"Josephs KA, Whitwell JL, Tacik P, Duffy JR, Senjem ML, Tosakulwong N, Jack CR, Lowe V, Dickson DW, Murray ME (2016) [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132:931\u2013933. doi:\n                    10.1007\/s00401-016-1618-1","journal-title":"Acta Neuropathol"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. doi:\n                    10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"key":"1740_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.24844","volume":"81","author":"M Marquie","year":"2017","unstructured":"Marquie M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Anton-Fernandez A, Klunk WE, Mathis CA, Ikonomovic MD, Debnath M et al (2017) Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol 81:117\u2013128. doi:\n                    10.1002\/ana.24844","journal-title":"Ann Neurol"},{"key":"1740_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787\u2013800. doi:\n                    10.1002\/ana.24517","journal-title":"Ann Neurol"},{"key":"1740_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","volume":"78","author":"N Mattsson","year":"2012","unstructured":"Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M et al (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78:468\u2013476. doi:\n                    10.1212\/WNL.0b013e3182477eed","journal-title":"Neurology"},{"key":"1740_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimer\u2019s Dis JAD 9:417\u2013423","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1640-3","volume":"132","author":"CT McMillan","year":"2016","unstructured":"McMillan CT, Irwin DJ, Nasrallah I, Phillips JS, Spindler M, Rascovsky K, Ternes K, Jester C, Wolk DA, Kwong LK et al (2016) Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132:935\u2013937. doi:\n                    10.1007\/s00401-016-1640-3","journal-title":"Acta Neuropathol"},{"key":"1740_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"1740_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K et al (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362\u2013381. doi:\n                    10.1097\/NEN.0b013e31825018f7","journal-title":"J Neuropathol Exp Neurol"},{"key":"1740_CR20","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/brain\/awt171","volume":"136","author":"BG Perez-Nievas","year":"2013","unstructured":"Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M et al (2013) Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology. Brain J Neurol 136:2510\u20132526. doi:\n                    10.1093\/brain\/awt171","journal-title":"Brain J Neurol"},{"key":"1740_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww334","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC et al (2017) Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain J Neurol. doi:\n                    10.1093\/brain\/aww334","journal-title":"Brain J Neurol"},{"key":"1740_CR22","doi-asserted-by":"publisher","unstructured":"Qian J, Hyman BT, Betensky RA (2017) Neurofibrillary tangle stage and the rate of progression of Alzheimer symptoms: modeling using an autopsy cohort and application to clinical trial design. JAMA Neurol. doi:\n                    10.1001\/jamaneurol.2016.5953","DOI":"10.1001\/jamaneurol.2016.5953"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ana.10161","volume":"51","author":"KP Riley","year":"2002","unstructured":"Riley KP, Snowdon DA, Markesbery WR (2002) Alzheimer\u2019s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51:567\u2013577. doi:\n                    10.1002\/ana.10161","journal-title":"Ann Neurol"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-8-20","volume":"8","author":"C Rosen","year":"2013","unstructured":"Rosen C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer\u2019s disease\u2014current concepts. Mol Neurodegener 8:20. doi:\n                    10.1186\/1750-1326-8-20","journal-title":"Mol Neurodegener"},{"key":"1740_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D et al (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718\u20131725. doi:\n                    10.1212\/01.wnl.0000261919.22630.ea","journal-title":"Neurology"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD, Schott JM, Revesz T, Fox NC, Arstad E (2016) Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 12:1116\u20131124. doi:\n                    10.1016\/j.jalz.2016.01.003","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1740_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD et al (2016) PET imaging of tau deposition in the aging human brain. Neuron 89:971\u2013982. doi:\n                    10.1016\/j.neuron.2016.01.028","journal-title":"Neuron"},{"key":"1740_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww023","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD Sr, Mintun MS (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain J Neurol. doi:\n                    10.1093\/brain\/aww023","journal-title":"Brain J Neurol"},{"key":"1740_CR29","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. doi:\n                    10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1740_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00401-016-1650-1","volume":"133","author":"R Smith","year":"2017","unstructured":"Smith R, Scholl M, Honer M, Nilsson CF, Englund E, Hansson O (2017) Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy. Acta Neuropathol 133:149\u2013151. doi:\n                    10.1007\/s00401-016-1650-1","journal-title":"Acta Neuropathol"},{"key":"1740_CR31","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O\u2019Keefe G, Ackerman U, Tochon-Danguy H, Chan JG et al (2011) Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med Off Publ Soc Nucl Med 52:1210\u20131217. doi:\n                    10.2967\/jnumed.111.089730","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"1740_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-007-0311-9","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 115:509\u2013532. doi:\n                    10.1007\/s00401-007-0311-9","journal-title":"Acta Neuropathol"},{"key":"1740_CR33","doi-asserted-by":"publisher","unstructured":"Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC et al (2016) Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between beta-amyloid and tauopathy. JAMA Neurol. doi:\n                    10.1001\/jamaneurol.2016.2078","DOI":"10.1001\/jamaneurol.2016.2078"},{"key":"1740_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP et al (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimer\u2019s Dement J the Alzheimer\u2019s Assoc 9:666\u2013676. doi:\n                    10.1016\/j.jalz.2012.11.008","journal-title":"Alzheimer\u2019s Dement J the Alzheimer\u2019s Assoc"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1740-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1740-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1740-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:46:58Z","timestamp":1589633218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1740-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1740-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]},"assertion":[{"value":"27 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Marta Marqui\u00e9 received research funding from the ASISA Foundation in Madrid, Spain. Alejandro Ant\u00f3n-Fern\u00e1ndez received funding from the Ministry of Economy and Competitiveness-State Secretariat for Research, Development and Innovation of Spain (SAF 2015-66603-P). Eline E.\u00a0Verwer received support from the Society of Nuclear Medicine and Molecular Imaging Education and Research Foundation. Marc D. Normandin received research funding from NIH National Institute of Neurological Disorders and Stroke (U01NS086659) and NIH National Institute of Mental Health (R01MH100350). Matthew P. Frosch received research funding from the Massahcusetts Alzheimer\u2019s Disease Research Center. Teresa G\u00f3mez-Isla received research funding from NIH National Institute on Aging (AG005134 and AG036694).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}